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1. Introduction 
In recent years, microarray gene expression studies have been actively pursued for 
extracting significant biological knowledge hidden under a large volume of gene expression 
profiles accumulated by DNA microarray experiments. Particularly great attentions have 
been paid to a variety of data mining schemes for gene function discovery [Eisen et al., 
1998], disease diagnosis [Saiki et al., 2008], pathway analysis [Werner et al., 2008], 
pharmaceutical target identification [Corn et al., 2007], and etc. Out of these, the pathway 
analysis is one of the most significant problems in current bioinformatics researches. 
Pathway analysis concerns about identifying significant pathways, which are the groups of 
genes actively involved in some biological processes, based on the gene expression profiles. 
By doing so, our objective is to understand the role of such biological processes in a given 
experiment condition and their associated gene activities. In this chapter, we investigate 
several computational techniques that are often used in a variety of contexts for pathway 
analysis. Specifically, we first give a brief overview of microarray gene expression profile 
data and some biological resources available to be used for pathway analysis. Then we 
examine three different approaches, i.e. clustering-based methods, gene-based methods, and 
Gene set-based methods, all of which can be employed for understanding biological 
pathways in various environments. Subsequently we perform some case studies with the 
leukemia disease data and finally conclude this chapter with some remarks and discussions. 
1.1 Overview of microarray gene expression profile data  
DNA microarray is generally a glass or plastic substrate, or silicon chip, onto which tens of 
thousands of DNA molecules (probes) are deposited in a regular grid-like pattern [Zhang, 
2006; Draghici, 2003]. Each grid spot corresponds to a DNA sequence of a specific gene. The 
idea of a microarray is to detect the presence and abundance of specific DNA molecules 
(targets) in biological samples of interests. For this purpose, from two mRNA samples (a test 
sample and a control sample), cDNAs are obtained and labeled with fluorescent dyes and 
the solutions including the labeled targets are hybridized on the surface of the chip. Then 
the chips are scanned to read the expression intensities emitted from the labeled and 
hybridized targets. Thus, by doing so, the microarray enables us to monitor the expression 
levels of tens of thousands of genes simultaneously. Once the raw microarray gene 
expression profiles are obtained in this way, several pre-processing steps are usually O
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performed which include data transformation, data filtering, missing value imputation, data 
normalization, and etc. Consequently, for the analysis of microarray data, the gene 
expression profiles are typically employed in a p × n matrix form as follows:  
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where xij denotes the expression intensity of the ith gene (i=1, …, p, p is the number of genes) 
in the jth sample (j=1, …, n, n is the number of experiment conditions). Thus, the procedure 
of obtaining gene expression data matrix from a collection of raw data obtained by 
microarray experiments can be summarized as in Fig. 1.  
 
 
Fig. 1. The procedure of obtaining gene expression data matrix from a collection of raw 
microarray data (adapted from [Brazma et al., 2001]). 
1.2 Biological resources for pathway analysis 
There exist several types of biological resources which can be used for pathway analysis, 
such as pathway databases, gene annotation databases, Gene Ontology, and etc. In 
particular, approximately 179 kinds of pathway databases are currently available and some 
of them are given in Table 1. These databases are easily accessible through a web and 
Include a collection of pathway maps already known for various organisms. The pathway 
maps represent the knowledge on molecular interaction and reaction networks in metabolic 
pathways, genetic networks, signaling pathways, and complexes. Some of the pathway 
databases provide application program interfaces (APIs) enabling us to access pathway data 
in various downloadable formats. Among them, the KEGG(Kyoto Encyclopedia of Genes 
and Genomes) database is one of the most well-known extensive pathway databases 
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including the information about the genes of 181 organisms, their associated pathways and 
graphical diagrams, which can be downloadable in KGML and XML formats. Similarly, 
there are some other useful pathway databases such as BioCyc, GenMapp, BioCarta, and etc.  
 
Pathway DB Organisms Pathway Types 
Downloadable 
Formats 
KEGG 181(varied) 
metabolic, genetic, 
signaling, complexes 
KGML, XML 
BioCyc 
E.Coli, human(20 
others) 
metabolic and complexes BioPax, SBML 
GeneMAPP 
human, mouse, rat, fly, 
yeast 
metabolic, signaling, 
complexes 
MAPP format 
Reactome 
human, rat, mouse, 
chicken, fugu, zebrafish
metabolic, signaling, 
complexes 
SBML, MySQL 
BioCarta human, mouse 
metabolic, signaling, 
complexes 
Just Images 
TransPATH human, mouse Signaling, genetic XML 
Table 1. Some examples of currently available pathway databases (adapted from 
http://bioinformatics.ca/) 
These pathway databases are also useful for evaluating and interpreting the analysis results 
of microarray gene expression profiles from the biological aspects. Fig. 2 shows an example 
of the acute myeloid leukaemia pathway map in KEGG pathway database.  
 
 
Fig. 2. An example of acute myeloid leukemia Pathway map in KEGG pathway database. 
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2. Computational methods for pathway analysis  
There are several computational approaches for pathway analysis which employ microarray 
gene expression profiles and a priori known biological knowledge such as Gene Ontology, 
KEGG pathway database, and etc. According to the aim of microarray experiments and 
analyses, an appropriate computational method can be chosen. Here three different 
approaches are detailed. First, the clustering-based methods are based on the assumption 
that the genes having similar expression profiles would have similar biological functions. 
Thus, the genes showing similar expression Patterns under a series of conditions are 
grouped into a cluster and its corresponding common functional pathways are identified. 
By doing so, the functional pathways of uncharacterized genes in a cluster may be possibly 
conjectured from the pathway categories of characterized genes in the same cluster. Second, 
the gene-based methods are the ones that can be applied for two-grouped samples data 
(e.g., treatment vs. control, cancer vs. normal). That is, their main purpose is to identify the 
differentially expressed genes (DEGs) between two groups and find out which functional 
pathways these DEGs are significantly involved in. Third, the gene set-based methods are 
intended to identify significant pathways (i.e. gene-sets) showing good differential 
expression between two groups from the candidate gene-sets each of which is generated by 
taking all the genes belonging to a certain pathway. The approach of gene set enrichment 
analysis (GSEA) by Subramanian et al. (2005) belongs here. Unlike earlier two approaches, 
this enables us to identify the most significant pathways in a unified analytical framework 
by employing a priori known biological knowledge along with gene expression profiles for 
the analysis. 
2.1 Clustering-based methods  
Conventionally cluster analysis for identifying groups of objects having similar 
characteristics. In our context, clustering methods are employed to generate groups of 
genes, i.e. gene clusters, showing similar expression profiles. The clustering-based approach 
for pathway analysis is based on the assumption that the co-expressed genes are of similar 
biological functions. Thus, once gene clusters are generated, the corresponding common 
functional pathways for each cluster are identified. For this purpose, Fisher’s exact test 
[Trajkovski et al., 2008] can be used with some biological resources like pathway databases 
or gene annotation databases. Also, for cluster generation, any clustering  methods are 
possibly used. Here we describe one of the most popular methods for microarray data 
analysis, which is hierarchical clustering. 
2.1.1 Cluster generation by hierarchical clustering 
To generate gene clusters, two types of hierarchical clustering methods can be used, top-
down and bottom-up approaches. The top-down approach is to start with one large cluster 
consisting of all genes and keep dividing them into smaller clusters until they become 
singleton clusters. On the other hand, the bottom-up approach is to start with as many 
singleton clusters as the gene size and keep grouping together two closest genes or clusters 
until they reach a single large cluster consisting of all genes. For gene expression data 
analysis, the bottom-up approach is generally used and the clustering results are Given in a 
tree-like graph, called dendrogram.  
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According to the way of defining the distance between two clusters in hierarchical clustering, 
which is called linkage method, some variations [Han et al., 2000] are possible as follows. 
• Single Linkage: The distance between two clusters CA and CB is defined as the 
minimum distance between any two genes each belonging to CA and CB, respectively. 
This method has the characteristics that the between-cluster distances are relatively 
small while the within-cluster distances are relatively large.   
 ( ) ,, min A BA B i C j C ijd C C d∈ ∈=  (1) 
• Complete Linkage: The distance between two clusters CA and CB is defined as the 
maximum distance between any two genes each belonging to CA and CB, respectively. 
This method has the characteristics that the within-cluster distances are relatively 
smaller than other linkage methods, since the maximum distance between two genes 
within a cluster is minimized. Because of this reason, it is the most popularly used. 
 ( ) ,, max A BA B i C j C ijd C C d∈ ∈=  (2) 
• Average Linkage: The distance between two clusters CA and CB is defined as an 
Average of the distances between any of two genes each belonging to CA and CB, 
respectively. Here nA is the number of genes in a cluster CA and nB is the number of 
genes in a cluster CB. This method is considered as a compromise between single 
linkage and complete linkage.  
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Also, several types of distance or similarity measures can be used for cluster generation, 
which include Euclidean distance, Manhattan distance, correlation coefficient, and etc. Each 
of these measures is described as below. 
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2.1.2 Pathway analysis for gene clusters 
Once gene clusters showing similar expression profiles are obtained by clustering method, 
for each cluster, the most representative common functional pathways need to be found. For 
this purpose, Fisher’s exact test [Trajkovski et al., 2008] can be applied to estimate the 
probability of having at least x genes in a given cluster annotated by a specific functional 
pathway. The probability of having exactly x genes, out of k genes in a cluster, annotated by 
a specific functional pathway S is given as follows. 
 ( | , , )
M N M
x k x
P X x N M k
N
k
−⎛ ⎞⎛ ⎞⎜ ⎟⎜ ⎟−⎝ ⎠⎝ ⎠= = ⎛ ⎞⎜ ⎟⎝ ⎠
 (4) 
 
Here N is the number of total genes on a microarray, M is the number of genes a priori 
known as belonging to a specific functional pathway S, N-M is the number of genes not 
included in S out of total N genes. The Fisher’s score p-value is thus calculated by using Eq. 
(5). For each of gene clusters, the corresponding significant pathways are extracted based on 
these p-values. In usual, the significance of functional pathways for a cluster are judged with 
p-value < 0.05.  
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2.2 Gene-based methods  
In analyzing the gene expression profiles consisting of two groups of samples (e.g. normal 
vs. cancer), some genes are expected to have significant difference in expression levels 
between two groups. We call these genes differentially expressed genes (DEGs), which are 
taken as the significant ones in a given experiment. Thus, the gene-based approach for 
pathway analysis is intended to identify DEGs first and then discover in which functional 
pathways the DEGs are actively involved. Prior to finding DEGs, some pre-processing like 
data filtering, log-transformation and normalization is generally performed on microarray 
expression profiles. 
2.2.1 Identifying DEGs 
When two-grouped microarray sample data are given, the differentially expressed genes can 
be identified by using one of the following methods, such as k-fold change, signal-to-noise 
ratio and t-test. 
• k-Fold Change [Draghici, 2003; Schena et al., 1996]: This method is to find significant 
genes by calculating the ratio of the averaged expression intensities over each group of 
samples as follows.  
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 ( ) ( )( )
A
B
i
i
i
μφ μ=  (6) 
Here μA(i) and μB(i) denote the averaged expression intensities of the ith gene over the 
samples each belonging to group A and group B, respectively. If such ratio for a gene is 
larger than the threshold, the gene is considered as being significantly changed in 
expression levels between two groups. In usual, by taking an arbitrary threshold k=2 or 
3, the DEGs are identified.  
• Signal-to-Noise Ratio (SNR) [Golub et al., 1999]: This method is to find significant genes 
by calculating the difference between the averaged expression intensities of two groups 
divided by the sum of their standard deviations. The SNR is computed as follows.    
 ( ) ( ) ( )( ) ( )A BA B
i i
i
i i
μ μρ σ σ
−= +  (7) 
In Eq. (7), μA(i) and μB(i) denote the averaged expression intensities of the ith gene over 
the samples each belonging to group A and group B, respectively. Also, A(i) and B(i) 
denote the standard deviations of group A and group B, respectively. Once the SNRs 
for entire genes are computed and arranged in a decreasing order, the corresponding 
graph is typically shown as in Fig. 3. The DEGs are taken from the both ends of the 
graph.  
 
 
Fig. 3. A typical form of SNR graph for the entire gene-list where the genes are arranged in a 
decreasing order of SNR values 
• t-test [Tusher et al., 2001; Dudoit et al., 2002]: This method is to find significant genes by 
calculating t-statistic and using t-distribution to obtain p-value. The t-statistic for a 
specific gene is computed as in Eq. (8).  
 ( ) ( ) ( )( ) ( )2 2
A B
A B
A B
i i
t i
i i
n n
μ μ
σ σ
−=
+
 (8) 
Here μA(i) and μB(i) denote the averaged expression intensities of the ith gene over the 
samples each belonging to group A and group B, respectively. Similarly, A(i) and B(i) 
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denote the standard deviations of group A and group B, respectively, while nA and nB 
denote the numbers of samples in group A and group B, respectively. As the absolute 
value of t-statistic for a specific gene is larger, the corresponding gene would have 
smaller p-value which implies higher significance in a statistical sense. Once the t-
statistics and p-values of all genes are obtained, we can take the genes having p-values 
less than a given significance level (generally, 0.01 or 0.05) as the DEGs. 
2.2.2 Pathway analysis for DEGs 
To identify functional pathways significantly involved by the DEGs, the Fisher’s exact test 
Can be used in the same way as described earlier, except that the meanings of some 
parameters are different. Specifically, in Eqs (4) and (5), k corresponds to the total number of 
the identified DEGs and x is the number of genes included in a specific functional pathway 
S out of k DEGs. Once the Fisher’s scores are computed for each of all the genes, significant 
functional pathways can be identified by taking the pathways having less than a specific p-
value. Also, the specific roles of the DEGs in these functional pathways might be understood 
by further analysis of the inter-relationships among the gene expression profiles of the 
DEGs. 
2.3 Gene set-based methods 
As a gene set-based method for pathway analysis, the gene set enrichment analysis (GSEA) 
approach has been attaining lots of attentions lately. In particular, the GSEA employs 
microarray expression profiles and a priori known biological resources in a unified analytical 
framework to identify significant pathways. That is, it generates the candidate gene-sets of 
interest, where a gene-set consists of the genes belonging to a specific pathway, by using a 
priori known biological resources such as pathway databases, gene annotation databases, 
literatures, and etc. Then, the significance of each candidate gene-set (i.e. pathway) is 
evaluated by using microarray gene expression profiles. Specifically, for each gene-set, the 
enrichment score is computed and its statistical significance is estimated. The detailed steps 
of GSEA are summarized in the following [Subramanian et al., 2005; Taskesen, 2006]:  
• Step 1: Computation of enrichment scores for gene-sets  
This step is to compute an enrichment score of a given gene-set A gene-set consists of the 
genes a priori known as being involved in a specific pathway and many candidate gene-sets 
can be constructed by using pathway databases, Gene Ontology, and etc. To compute ES, 
the entire gene-list should be rearranged in the order of Ranking statistic such as SNR or 
Fisher’s criterion [Kim et al., 2008]. Then, with the ordered gene-list, the Kolmogorov-
Smirnov(KS) score is computed for each gene-set. For KS score, the empirical cumulative 
distribution functions For Phit and Pmiss are employed as shown in Eq. (11).  
 
( ) ( )
( ) ( )( )
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1
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h i t
j H
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N N
=
=
=
−= −
∑
∑
 (11) 
Here Phit is the empirical cumulative distribution function of which cumulative sum 
becomes 1 when the first i genes in the ordered gene-list completely match the genes 
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included in a specific gene-set S. On the other hand, Pmiss is the one of which cumulative 
sum becomes 1 when there is no match between them. In Eq. (11), E(j) is 1 if the jth gene in 
the ordered gene-set is included in a given gene-set (i.e. hit), or is 0 if the jth gene in the 
ordered gene-set is not included in a given gene-set (i.e. miss). Also N is the total number of 
genes in entire gene-list and NH is the number of genes in a specific gene-set S. At times, the 
ranking statistic can be used for computing Phit and Pmiss [Taskesen, 2006]. For instance, 
assuming that the SNR-based gene ranking is used, E(j) Can be replaced by the SNR value of 
the jth gene in the ordered gene-list while N is the sum of the SNR values for total genes 
included in entire gene-list and NH is the sum of the SNR values for the genes included in a 
specific gene-set S. In either way, by taking the maximum deviation between Phit and Pmiss, 
as shown in Eq. (12), the ES for a specific gene-set S is obtained.  
 ( ) ( )
1, ,
( ) max
hit miss
i N
ES S P i P i
=
= −
A
 (12) 
• Step 2: Estimation of statistical significance of ES  
To estimate statistical significance of the ES obtained in step 1, k random permutations of a 
given microarray expression profile data on labels are generated and for each permutation, 
the corresponding ES is calculated. By using the computed ESs for k permuted data, we can 
obtain the null distribution of ES which will be used to calculate a nominal p-value of the ES.  
• Step 3: Adjustment for multiple hypothesis testing  
The estimated significance level is now adjusted to account for multiple hypothesis testing. 
First, the ES for each candidate gene-set is normalized for the gene-set size by dividing it 
with the mean of the k ESs for the permuted data obtained in Step 2. Then, for each 
normalized ES, the proportion of false positives is controlled by calculating the 
corresponding false discovery rate (FDR) or the family-wise error rate (FWER). 
3. Case studies 
For experiments, the leukemia dataset published by Golub et al. [1999] was used. The 
leukemia disease [Knudsen, 2006] is known as a cancer of the blood or bone marrow that 
affects blood-forming cells (usually white blood cells) in the bone marrow. The white blood 
cells are divided into granulocytes, monocytes, and lymphocytes. Leukemias starting in 
granulocytes or monocytes are called myeloid leukemias, and leukemias starting in 
lymphocytes are called lymphocytic leukemias. Further, leukemias are divided into acute and 
chronic. In acute leukemias, the cells cannot mature properly, whereas in chronic leukemias, 
the cells mature partly but do not obtain their full function. The Golub’s leukemia dataset 
originally consists of 7129 human gene expression profiles shown in total 78 leukemia 
samples of two classes including 47 acute lymphoblastic leukemia(ALL) samples and 25 
acute myeloid leukemia (AML) samples. Out of them, Golub et al. used 38 samples for 
training and 34 samples for testing to diagnose the subtypes of the leukemia. For our 
analyses, these 38 training samples including 27 ALL samples and 11 AML samples were 
used. 
3.1 Pathway analysis with clustering  
For cluster analysis, the data-filtering and data-transformation were applied for microarray 
expression profiles in the same way as in [Dudoit et al., 2002]. Specifically, the data-
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transformation was done to replace the expression intensities less than 100 with 100 and 
expression intensities larger than 16000 with 16000. Also, the log-transformation with base 2 
was applied for all the gene expression profiles. After such data-transformation, data-
filtering was performed to remove the genes whose the difference between the maximum 
and the minimum of expression intensities is less than 500 or the ratio of the maximum to 
the minimum of expression intensities is less than 5. As a result, 3051 genes were remained 
and used for cluster generation. Clusters were generated by using complete-linkage 
hierarchical clustering with Euclidean distance and the results are shown in Fig. 6. By visual 
inspection of Fig. 6, the four was chosen to be an appropriate number of clusters. Thus, we 
generated four clusters and obtained the results as shown in Fig. 7, where four clusters 
include 666 genes, 656 genes, 427 genes, and 1302 genes, respectively. 
 
Fig. 6. Clustering result of Golub’s leukemia dataset by complete-linkage hierarchical 
clustering with Euclidean distance. 
To identify significant functional pathways involved in each cluster, we used KEGG 
pathway database to perform Fisher’s exact test on the genes in a cluster. By using p-
value≤0.05, the significant pathways for each of the four clusters were identified and shown 
in Tables 2-5. 
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Fig. 7. Heatmap for four clusters of Golub’s leukemia dataset obtained by complete-linkage 
hierarchical clustering with Euclidean distance measure  
functional pathways p -values 
Hematopoietic cell lineage 3.7e-7 
Type I diabetes mellitus 2.9e-5 
Antigen processing and presentation 5.1e-5 
Cytokine-cytokine receptor interaction 0.00013 
Epithelial cell signaling in Helicobacter pylori infection 0.00042 
Cell adhesion molecules (CAMs) 0.00067 
Adipocytokine signaling pathway 0.00086 
Toll-like receptor signaling pathway 0.00097 
Porphyrin and chlorophyll metabolism 0.0012 
Acute myeloid leukemia 0.0029 
Aminosugars metabolism 0.035 
Glutathione metabolism 0.042 
Table 2. 1st cluster’s significant functional pathways (p -value≤0.05) 
functional pathways p -values 
Hematopoietic cell lineage 6.8e-7 
B cell receptor signaling pathway 0.0048 
Aminoacyl-tRNA biosynthesis 0.011 
Insulin signaling pathway 0.016 
Long-term potentiation 0.043 
Alzheimer's disease 0.049 
Table 3. 2nd cluster’s significant functional pathways (p -value≤0.05) 
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functional pathways p -values 
Metabolism of xenobiotics by cytochrome P450 0.003 
Linoleic acid metabolism 0.013 
Colorectal cancer 0.013 
VEGF signaling pathway 0.013 
Small cell lung cancer 0.015 
Pancreatic cancer 0.016 
gamma-Hexachlorocyclohexane degradation 0.018 
Non-small cell lung cancer 0.028 
Neurodegenerative Diseases 0.029 
Focal adhesion 0.032 
Apoptosis 0.033 
Acute myeloid leukemia 0.035 
Prostate cancer 0.04 
Chronic myeloid leukemia 0.047 
Table 4. 3rd cluster’s significant functional pathways (p -value≤0.05) 
functional pathways p -values 
Glioma 2.0e-5 
Chronic myeloid leukemia 5.7e-5 
Prostate cancer 0.0001 
Cell cycle 0.00024 
Glycolysis / Gluconeogenesis 0.00074 
Endometrial cancer 0.00078 
T cell receptor signaling pathway 0.00092 
Thyroid cancer 0.00098 
Non-small cell lung cancer 0.0012 
Small cell lung cancer 0.0018 
Regulation of actin cytoskeleton 0.0027 
Adherens junction 0.0035 
Long-term potentiation 0.0051 
Focal adhesion 0.0072 
Oxidative phosphorylation 0.0073 
Natural killer cell mediated cytotoxicity 0.0081 
Gap junction 0.012 
Proteasome 0.014 
Acute myeloid leukemia 0.015 
Colorectal cancer 0.016 
ErbB signaling pathway 0.016 
Renal cell carcinoma 0.016 
Carbon fixation 0.018 
Melanoma 0.021 
Bladder cancer 0.022 
Huntington's disease 0.022 
Pancreatic cancer 0.033 
Calcium signaling pathway 0.038 
Insulin signaling pathway 0.041 
Neurodegenerative Diseases 0.047 
Table 5. 4th cluster’s significant functional pathways (p -value≤0.05) 
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According to earlier Golub’s study on this leukemia dataset, it was observed that their gene 
expression profiles can be grouped into AML related samples, ALL-T-cell related samples, 
ALL-B-cell related samples. To understand the biological meaning of our analysis results, 
thus, we analyzed whether significant functional pathways identified for each cluster are 
somewhat related to AML or ALL-T-cell or ALL-B-cell types and found some interesting 
observations. In Tables 2 and 4, it was observed that the genes in the 1st cluster and 3rd 
cluster are significantly involved in AML-related functional pathways such as hematopoietic 
cell lineage, apoptosis, and acute myeloid leukemia. Also, in Tables 3 and 5, it was observed 
that the genes in the 2nd cluster are significantly involved in ALL-B-cell related pathways 
such as hematopoietic cell lineage and B cell receptor signaling pathway, while the genes in 
the 4th cluster are significantly involved in ALL-T-cell related pathways such as T cell 
receptor signaling pathway and cell cycle. Consequently, from our experiments, it was 
found that each of the four clusters is closely related to the subtypes of the leukemia which 
include AML, ALL-T-cell, and ALL-B-cell types. 
3.2 Pathway analysis with DEGs 
To apply the gene-based method described earlier for pathway analysis, we need to find 
differentially expressed genes first. For this purpose, the data-filtering and data-
transformation were applied for Golub’s 7129 gene expression profiles in the same way as 
done for pathway analysis with clustering, and  3051 genes were obtained. Out of these 
genes, we extracted the most 50 differentially expressed genes by using SNR and the 
results are shown in Fig. 8. In this figure, we can see 25 DEGs showing relatively higher 
expression in ALL than AML, and the other 25 DEGs showing relatively higher 
expression in AML than ALL. This is why the DEGs were chosen by taking the genes 
having the 25 largest SNRs in positive region and the 25 smallest SNRs in negative region. 
Also, for comparisons, we applied t-test for 3051 gene expression profiles and selected 50 
genes as the DEGs by having p-value≤0.000004, as shown in Fig. 9.. When the t-test is used 
for finding DEGs, the different number of DEGs can be chosen depending on the choice of 
p-value. In our case, we adjusted p-value in such a way to choose 50 genes, for 
comparative purpose with the SNR result. As seen in Figs 8 and 9, even if the same 
number of DEGs are chosen by SNR method and t-test, respectively, it is observed that the 
identified DEGs are quite different.  
To understand significant functional pathways in which the DEGs identified by SNR 
method and t-test are actively involved, the Fisher’s exact test was applied for the both 
cases. Table 6 shows the result Of significant functional KEGG pathways identified for the 
SNR DEGs while Table 7 shows the pathway analysis result for the t-test DEGS. As seen in 
Tables 6 and 7, the same pathways were identified for the two different sets of 50 DEGs 
chosen by SNR method and t-test, respectively. In particular, the pathway of hematopoietic 
cell lineage is known as being related to both ALL and AML types, and the B cell receptor 
signaling pathway is related to ALL-B-cell type. Thus, the DEGs showing significant 
expression difference between two groups of ALL and AML are empirically found to be 
actively involved in hematopoietic cell lineage and B cell receptor signaling pathway. In 
addition, it is observed that the DEGs identified by the t-test seem to be more meaningful in 
terms of p-values than the DEGs identified by the SNR. 
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Fig. 8. Heatmap of 50 differentially expressed genes identified by SNR. 
 
Fig. 9. Heatmap of 50 differentially expressed genes identified by t-test. 
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functional pathways p-values 
Hematopoietic cell lineage 0.0081 
B cell receptor signaling pathway 0.041 
Table 6. Significant functional KEGG pathways identified for 50 DEGs by SNR method (p-
value≤0.05) 
functional pathways p-values 
Hematopoietic cell lineage 0.005 
B cell receptor signaling pathway 0.01 
Table 7. Significant functional KEGG pathways identified for 50 DEGs by t-test method (p-
value≤0.000004) 
3.3 Pathway analysis by gene set enrichment analysis 
To perform pathway analysis with GSEA, the z-score normalization was first applied for 
7129 gene expression profiles. Also, 136 candidate gene-sets were generated from KEGG 
pathway database in such a way to take only the pathways each of which include at least 10 
genes out of 7129 genes. Then, for each of the candidate gene-sets, the corresponding ES was 
computed, and its statistical significance level and the normalized ES were obtained with 
1000 random permutations of 7129 gene expression profiles on class labels. In particular, the 
normalized ESs for the candidate gene-sets has a two-modal distribution as shown in Fig. 
10. Thus, the most 40 significant pathways were identified as done in [Subramanian et al., 
2005] by taking 20 gene-sets from the rightmost end in a positive region and 20 gene-sets 
from the leftmost end in a negative region. The results are shown as in Table 8. 
 
Fig. 10. The distribution of normalized ESs for the candidate gene-sets 
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functional pathways 
 
Normalized ES 
Pyruvate metabolism 1.759 
Cell cycle 1.718 
Galactose metabolism 1.511 
Alanine and aspartate metabolism 1.500 
Basal transcription factors 1.497 
DNA polymerase 1.496 
Aminoacyl-tRNA biosynthesis 1.481 
Purine metabolism 1.463 
Citrate cycle (TCA cycle) 1.445 
Proteasome 1.440 
Pentose and glucuronate interconversions 1.377 
One carbon pool by folate 1.369 
1- and 2-Methylnaphthalene degradation 1.360 
Pyrimidine metabolism 1.327 
Biosynthesis of steroids 1.311 
Lysine degradation 1.296 
Wnt signaling pathway 1.266 
Folate biosynthesis 1.260 
Butanoate metabolism 1.248 
RNA polymerase 1.209 
Apoptosis -1.150 
Neurodegenerative Disorders -1.177 
ECM-receptor interaction -1.204 
Metabolism of xenobiotics by cytochrome P450 -1.216 
Glycosphingolipid biosynthesis - neo-lactoseries -1.219 
Cytokine-cytokine receptor interaction -1.249 
Methane metabolism -1.280 
Sphingolipid metabolism -1.308 
Leukocyte transendothelial migration -1.323 
Hematopoietic cell lineage -1.378 
Glycan structures - degradation -1.438 
Nitrogen metabolism -1.477 
Complement and coagulation cascades -1.497 
Toll-like receptor signaling pathway -1.656 
Glycosaminoglycan degradation -1.682 
Arachidonic acid metabolism -1.754 
Glutathione metabolism -1.755 
Epithelial cell signaling in Helicobacter pylori infection -1.778 
Porphyrin and chlorophyll metabolism -1.805 
Adipocytokine signaling pathway -1.810 
Table 8. The most 40 significant pathways identified by GSEA for Golub’s 7129 gene 
expression profiles 
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As seen in Table 8, It is interesting that the pathways including an apoptosis pathway 
known as being related to cell death, or the hematopoietic cell lineage known as being 
related to generating an antibody in a blood were identified as significant pathways. Also, 
some other cancer-related pathways were found. 
4. Concluding remarks 
In this chapter we introduced several mining methods for biological pathway analysis with 
microarray gene expression profiles. For pathway analysis, our concern is how to identify 
significant functional pathways in which many genes showing differential expression 
between treatment and control groups are actively involved. In earlier approaches, the 
computational techniques only for microarray data had been more focused than biological 
interpretation of the results. On the other hand, the recent approaches concentrate more on 
the effective use of a variety of biological resources in analyzing large volume of microarray 
expression data to obtain more biologically meaningful results. By applying them for a 
variety of fields such as drug discovery [Bild et al., 2006] or disease diagnosis[Watters et al., 
2006], pathway analysis with microarray expression data can play a key role in the path to 
new scientific discoveries and allows us to understand what biological phenomena causes 
the observed expression patterns. Furthermore, by making an attempt to use new types of 
biological resources along with expression profiles for the analysis, our understanding of the 
expression data could be enhanced in a deeper manner. 
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